McKesson Corporation

MCK Healthcare Medical Distribution

McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025. In the quarter to June 2026, revenue grew 7.72%, EPS fell 17.7%, free cash flow grew 66.4% and total debt rose 10.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for ten.

1,006.92 8.28 +0.83%
Market cap
$116.4B
P/E
26.8×
Fwd P/E
18.3×
Dividend yield
0.34%
F-score
7/9
Altman Z
6.15
Beneish M
−2.34
Dividend safety
86/100

McKesson Corporation (MCK) P/B ratio

Alert me on P/B ratio

McKesson Corporation has no meaningful P/B ratio: its trailing twelve-month book value is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 186× (May 2021) — the current reading is the lowest in ten years.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2026 0.0× —
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 179× 3,790.09%
FY2020 4.6× 63.45%
FY2019 2.8× (2.65%)
FY2018 2.9× (0.51%)
FY2017 2.9× (27.61%)

Quarterly newest first

Period P/B ratio Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 0.0× —
42 more quarters

Against its own ten years

Low 0.0× High 186×
Ten-year median 2.6×
Current reading's percentile 47

P/B ratio against peers

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on MCK